144 related articles for article (PubMed ID: 25430026)
1. [Clinical significance of expression of enhancer of zeste homolog 2 and 53 in cervical squamous cell carcinoma and intraepithelial neoplasia].
Zhang H; Chen S; Niu G; Jiang H; Yao S
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):597-601. PubMed ID: 25430026
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix.
Zhang HM; Chen SQ; Yao SZ
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323178
[TBL] [Abstract][Full Text] [Related]
3. Analyzing simultaneous positive expression of EZH2 and P53 protein to improve predictive value in cervical squamous cell carcinoma.
Chen SQ; Zhang HM; Li JB; Jiang HY; Fan L; Kong LZ; Yao SZ
Int J Gynecol Cancer; 2014 Nov; 24(9):1653-8. PubMed ID: 25275664
[TBL] [Abstract][Full Text] [Related]
4. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis.
Liu Y; Liu T; Bao X; He M; Li L; Yang X
Int J Gynecol Pathol; 2014 May; 33(3):218-24. PubMed ID: 24681730
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of EZH2 is associated with pathological findings and P53 alteration.
Shiogama S; Yoshiba S; Soga D; Motohashi H; Shintani S
Anticancer Res; 2013 Oct; 33(10):4309-17. PubMed ID: 24122997
[TBL] [Abstract][Full Text] [Related]
6. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang H; Wang M; Lian G; Wu D
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):99-102. PubMed ID: 23353165
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
[TBL] [Abstract][Full Text] [Related]
8. [Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].
Wang HR; Wang MH; Lian GY; Wu DG
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):99-102. PubMed ID: 25613619
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53, bcl-2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
Ha SY; Kim SH
Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
[TBL] [Abstract][Full Text] [Related]
11. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
12. [The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix].
Nai MM; Yin RT; Xie C; Kang DY; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):236-9. PubMed ID: 19462897
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of differentially expressed proteins in normal cervix, cervical intraepithelial neoplasia and cervical squamous carcinoma tissues].
Zhao Q; Wu YM; He Y; Wang XL; Chen S; Qian XH; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):914-20. PubMed ID: 24506961
[TBL] [Abstract][Full Text] [Related]
14. IMP3 expression is associated with poor survival in cervical squamous cell carcinoma.
Wei Q; Yan J; Fu B; Liu J; Zhong L; Yang Q; Zhao T
Hum Pathol; 2014 Nov; 45(11):2218-24. PubMed ID: 25176620
[TBL] [Abstract][Full Text] [Related]
15. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.
Wang JL; Zheng BY; Li XD; Angström T; Lindström MS; Wallin KL
Clin Cancer Res; 2004 Apr; 10(7):2407-14. PubMed ID: 15073118
[TBL] [Abstract][Full Text] [Related]
16. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
[TBL] [Abstract][Full Text] [Related]
17. p53 in surgically treated and pathologically staged cervical cancer: correlation with local tumor progression, but not with lymphatic spread.
Horn LC; Fischer U; Hänel C; Kuhn H; Raptis G; Bilek K
Pathol Res Pract; 2001; 197(9):605-9. PubMed ID: 11569924
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in carcinoma of the cervix.
Hunt CR; Hale RJ; Buckley CH; Hunt J
J Clin Pathol; 1996 Dec; 49(12):971-4. PubMed ID: 9038732
[TBL] [Abstract][Full Text] [Related]
19. nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
Lee CS; Gad J
Pathol Int; 1998 Oct; 48(10):806-11. PubMed ID: 9788265
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of p53 pathway genes and EZH2 in undifferentiated nasopharyngeal carcinoma].
Liu XD; Ji MF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1029-33. PubMed ID: 21690062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
